PFIZER marked World Metastatic
Breast Cancer Day earlier this week
with the further commitment of
$300,000 in funding over three
years to the McGrath Foundation.
The money will fund a dedicated
Metastatic Breast Cancer nurse,
with McGrath Foundation ceo Petra
Buchanan saying the needs for
patients with metastatic disease are
quite different.
Approximately 30% of primary
breast cancer patients will develop
secondaries, while 6% will be
metastatic at diagnosis.
The median survival rate
following a metastatic breast
cancer diagnosis is just three years,
with an estimated 9,000 women
currently living with secondary
breast cancer in Australia.
Representatives from Pfizer
handed over a giant novelty cheque
to the McGrath Foundation at an event in
Sydney on Wednesday.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Oct 15
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.